X-Therma Receives FDA Breakthrough Device Designation for XT-ViVo® Preservation Solution and TimeSea

RICHMOND, Calif.--(BUSINESS WIRE)--X-Therma Inc., a biotechnology company developing breakthrough technology for regenerative medicine and organ preservation - announced today that The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) has granted its proprietary organ preser...

Related Keywords

San Francisco Bay ,California ,United States ,Berkeley ,Austria ,Mark Kline ,Xiaoxi Wei ,Us Department Of Defense ,California Institute For Regenerative Medicine ,Radiological Health ,Drug Administration ,Lawrence Berkeley National Laboratory ,National Science Foundation ,X Therma Inc ,Organ Transport Device ,Breakthrough Device ,San Francisco Bay Area ,Regenerative Medicine ,Industrial User ,California Institute ,